These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37526705)

  • 21. Successful treatment with tocilizumab every 4 weeks of a low disease activity group who achieve a drug-free remission in patients with systemic-onset juvenile idiopathic arthritis.
    Kostik MM; Dubko MF; Masalova VV; Snegireva LS; Kornishina TL; Chikova IA; Isupova EA; Kuchinskaya EM; Glebova NI; Buchinskaya NV; Kalashnikova OV; Chasnyk VG
    Pediatr Rheumatol Online J; 2015; 13():4. PubMed ID: 25685108
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flares After Withdrawal of Biologic Therapies in Juvenile Idiopathic Arthritis: Clinical and Laboratory Correlates of Remission Duration.
    Simonini G; Ferrara G; Pontikaki I; Scoccimarro E; Giani T; Taddio A; Meroni PL; Cimaz R
    Arthritis Care Res (Hoboken); 2018 Jul; 70(7):1046-1051. PubMed ID: 28973842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Intraarticular Corticosteroid Foot Injections on Walking Function in Children With Juvenile Idiopathic Arthritis.
    Esbjörnsson AC; Iversen MD; André M; Hagelberg S; Schwartz MH; Broström EW
    Arthritis Care Res (Hoboken); 2015 Dec; 67(12):1693-701. PubMed ID: 26017638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical comparison of early-onset psoriatic and non-psoriatic oligoarticular juvenile idiopathic arthritis.
    Stoll ML; Nigrovic PA; Gotte AC; Punaro M
    Clin Exp Rheumatol; 2011; 29(3):582-8. PubMed ID: 21385553
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Remission status follow-up in children with juvenile idiopathic arthritis.
    Fernandes TA; Corrente JE; Magalhães CS
    J Pediatr (Rio J); 2007; 83(2):141-8. PubMed ID: 17380231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Is tear proteome profile a predictor of developing uveitis in ANA-positive patients with oligoarticular juvenile idiopathic arthritis?
    Yılmaz Tuğan B; Sarıhan M; Kasap M; Akpınar G; Karabaş L; Şahin N; Yüksel N; Bayrak YE; Sönmez HE
    Graefes Arch Clin Exp Ophthalmol; 2024 Jan; 262(1):211-221. PubMed ID: 37773290
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow-Up in the Population-Based Nordic Juvenile Idiopathic Arthritis Cohort.
    Glerup M; Rypdal V; Arnstad ED; Ekelund M; Peltoniemi S; Aalto K; Rygg M; Toftedal P; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2020 Apr; 72(4):507-516. PubMed ID: 30762291
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intra-articular corticosteroid utilization and characterizations of use in juvenile idiopathic arthritis within the PR-COIN registry.
    Balay-Dustrude E; Weiss JE; Goh YI; Rubin N; Bullock DR
    Front Pediatr; 2024; 12():1423362. PubMed ID: 39108690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of efficacy between triamcinolone acetonide and triamcinolone hexacetonide for intraarticular therapy in juvenile idiopathic arthritis: a retrospective analysis.
    Chun A; Muhammad LN; De Ranieri D
    BMC Rheumatol; 2022 Mar; 6(1):18. PubMed ID: 35354497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The DNA methylation landscape of CD4
    Chavez-Valencia RA; Chiaroni-Clarke RC; Martino DJ; Munro JE; Allen RC; Akikusa JD; Ponsonby AL; Craig JM; Saffery R; Ellis JA
    J Autoimmun; 2018 Jan; 86():29-38. PubMed ID: 28969936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate withdrawal at 6 vs 12 months in juvenile idiopathic arthritis in remission: a randomized clinical trial.
    Foell D; Wulffraat N; Wedderburn LR; Wittkowski H; Frosch M; Gerss J; Stanevicha V; Mihaylova D; Ferriani V; Tsakalidou FK; Foeldvari I; Cuttica R; Gonzalez B; Ravelli A; Khubchandani R; Oliveira S; Armbrust W; Garay S; Vojinovic J; Norambuena X; Gamir ML; García-Consuegra J; Lepore L; Susic G; Corona F; Dolezalova P; Pistorio A; Martini A; Ruperto N; Roth J;
    JAMA; 2010 Apr; 303(13):1266-73. PubMed ID: 20371785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis.
    Ravelli A; Viola S; Migliavacca D; Ruperto N; Pistorio A; Martini A
    J Pediatr; 1999 Sep; 135(3):316-20. PubMed ID: 10484796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Juvenile Arthritis Disease Activity Score proves to be a useful tool in treat-to-target therapy in juvenile idiopathic arthritis.
    Swart JF; van Dijkhuizen EHP; Wulffraat NM; de Roock S
    Ann Rheum Dis; 2018 Mar; 77(3):336-342. PubMed ID: 29138257
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of clinical remission in select categories of juvenile idiopathic arthritis.
    Wallace CA; Huang B; Bandeira M; Ravelli A; Giannini EH
    Arthritis Rheum; 2005 Nov; 52(11):3554-62. PubMed ID: 16255044
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequency of juvenile idiopathic arthritis and associated uveitis in pediatric rheumatology clinics in Turkey: A retrospective study, JUPITER.
    Sahin S; Acari C; Sonmez HE; Kilic FZ; Sag E; Dundar HA; Adrovic A; Demir S; Barut K; Bilginer Y; Sozeri B; Unsal E; Ozen S; Kasapcopur O
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):134. PubMed ID: 34425847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of medication withdrawal method on flare-free survival in patients with juvenile idiopathic arthritis on combination therapy.
    Chang CY; Meyer RM; Reiff AO
    Arthritis Care Res (Hoboken); 2015 May; 67(5):658-66. PubMed ID: 25220674
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Delineating the role of multiple intraarticular corticosteroid injections in the management of juvenile idiopathic arthritis in the biologic era.
    Papadopoulou C; Kostik M; Gonzalez-Fernandez MI; Bohm M; Nieto-Gonzalez JC; Pistorio A; Lanni S; Consolaro A; Martini A; Ravelli A
    Arthritis Care Res (Hoboken); 2013 Jul; 65(7):1112-20. PubMed ID: 23335483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile idiopathic arthritis management: insights into the utilization of intra-articular corticosteroid injections.
    Yıldız Ç; Küçükali B; Kutlar M; Belder N; Karaçayır N; Esmeray Şenol P; Sunar Yayla EN; Yildirim DG; Bakkaloğlu SA
    Postgrad Med; 2024 Nov; 136(8):883-889. PubMed ID: 39365706
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patients with juvenile idiopathic arthritis in clinical remission with positive power Doppler signal in joint ultrasonography have an increased rate of clinical flare: a prospective study.
    Miotto E Silva VB; Mitraud SAV; Furtado RNV; Natour J; Len CA; Terreri MTSELRA
    Pediatr Rheumatol Online J; 2017 Nov; 15(1):80. PubMed ID: 29132381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changing Patterns in Treatment, Remission Status, and Categories in a Long-Term Nordic Cohort Study of Juvenile Idiopathic Arthritis.
    Glerup M; Arnstad ED; Rypdal V; Peltoniemi S; Aalto K; Rygg M; Nielsen S; Fasth A; Berntson L; Nordal E; Herlin T;
    Arthritis Care Res (Hoboken); 2022 May; 74(5):719-727. PubMed ID: 35015381
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.